NAD+ Metabolic Reprogramming Drives CD8+ T Cells Senescence and Exacerbates Ulcerative Colitis
Key claim: NAD+ metabolic reprogramming drives senescence of CD8+ T cells and thereby exacerbates ulcerative colitis.
Abstract
Aging Cell, Volume 25, Issue 9, September 2026.
Why this matters
NAD+ decline is heavily marketed via NR/NMN supplements as a general anti-aging lever, but this study places NAD+ metabolism upstream of a specific pathological output — CD8 T-cell senescence driving ulcerative colitis severity via mtDNA–cGAS–STING — rather than a diffuse healthspan claim. It extends the senescence/inflammaging picture into adaptive immunity and an autoimmune tissue context, and hints that NAD+ status may modulate response to conventional IBD anti-inflammatories. Preclinical mouse causality plus human correlational signal only; no NAD-repletion or senolytic trial in UC patients yet.